The 2022 NVBF will be held at University of Liverpool on the 7th of December 2022; 09:00-17:00. This event brings together researchers from 12 universities from 8 cities across the north of England and will showcase the latest in vascular and related research. The meeting will feature presentations from both internationally renowned scientists and early career researchers.
This free one-day conference will be held in Spaces at the Spine close to the University campus.
|9.30 am||Arrival and coffee|
|10 am||Welcome||Dr Jill Madine & Prof Gregory Y. H. Lip|
|10.15 am||Liverpool John Moores University||Dr Yasina Somani
Exercise and vascular protection in people with cardiovascular risk: how quickly can the arteries benefit?
Meike van Wuijswinkel
Carotid artery reactivity and cardiovascular risk factors in patients awaiting CABG: is there a link?
|10.40 am||University of Liverpool||Dr Riaz AkhtarThe unique nature of Bicuspid Aortic Valve aortopathy – from amyloid to elastin
Doxorubicin mediated impairment of vascular tone and recovery by the NRF2 antioxidant pathway activator CDDO
|11.05 – 11.45||Coffee / Posters / Exhibitors|
|11.45 – 12.35||Keynote Talk – Chair Dr Riaz Akhtar||Prof Kennedy Cruickshank Measuring and Using Arterial Function in Humans|
|12.35 – 1.35 pm||Lunch / Posters / Exhibitors|
|1.35 pm||University of Bradford||Sabita ShahaTherapeutic Resolution of Pulmonary Arterial Hypertension (PAH) By Established Drugs|
|1.55 pm||Sheffield Hallam||Liam RidgePotential application of an ex-vivo cell culture model to probe vascular cell responsiveness to signalling gradients
Circulation Models.jl – A fresh approach to lumped parameter modelling
The acute cerebral haemodynamic effects of in-bed leg cycling exercise in acute stroke
|2.20 pm||University of Wolverhampton||Kinza KhanRole of the Plasma Membrane Calcium ATPase 4 in arterial inflammation.
PMCA4 in Pulmonary Arterial Hypertension
|2.45 – 3.25 pm||Coffee / Posters / Exhibitors|
|3.25 pm||University of Hull||Dr Giordano PulaNovel peptides selectively inhibiting platelet-leukocyte aggregation and their potential for the treatment of thrombo-inflammatory conditions|
|3.45 pm||University of Leeds||Dr Katie SimmonsA small molecule reveals role of insulin receptor-insulin like growth factor-1 receptor heterodimers
Dr Paul Meakin
BACE1: A novel regulator of the microcirculation from head to toe
Dr Laeticia Lichtenstein
Piezo1 in lipid homeostasis
Dr Chloe Myers
Detecting Hidden Markers to Investigate and Diagnose Diabetic Vascular Disease
Dr Chew Cheng
Association of PIEZO1 channels with COVID-19
|4.10 pm||Manchester Metropolitan University||Rhys Smith Microplastic BPA Activates a Multifactorial Stress Response and Downregulates Protective Pathways Known to Affect Cardiovascular Risk
Dr Sophie Nock
Pim kinase inhibitors as anti-thrombotics – a novel Thromboxane receptor targeting strategy
Dr Rehan Junejo
E-cigarettes: not the harmless alternative we imagined
|4.35 pm||Closing remarks and prizes||Dr Rich Rainbow & Dr Jill Madine|
Registration is free for all attendees and is now open, deadline for registration 9am Monday 28th November. Please register here.
Please submit your abstracts on the “Abstract Submission” tab by 21st November 2022. Abstracts should include the Title, Authors and Affiliations. The main body of the abstract should be structured to include Introduction, Methods, Results, Conclusions and should be no more than 250 words.
We are very grateful to the British Heart Foundation and Liverpool Centre for Cardiovascular Sciences for supporting this meeting and to our commercial sponsors;